136 related articles for article (PubMed ID: 23997284)
1. From newborn screening to population health research: implementation of the Michigan BioTrust for health.
Langbo C; Bach J; Kleyn M; Downes FP
Public Health Rep; 2013; 128(5):377-84. PubMed ID: 23997284
[TBL] [Abstract][Full Text] [Related]
2. Michigan BioTrust for Health: public support for using residual dried blood spot samples for health research.
Duquette D; Langbo C; Bach J; Kleyn M
Public Health Genomics; 2012; 15(3-4):146-55. PubMed ID: 22488457
[TBL] [Abstract][Full Text] [Related]
3. The Michigan BioTrust for Health: using dried bloodspots for research to benefit the community while respecting the individual.
Chrysler D; McGee H; Bach J; Goldman E; Jacobson PD
J Law Med Ethics; 2011 Mar; 39 Suppl 1():98-101. PubMed ID: 21309908
[No Abstract] [Full Text] [Related]
4. The Influence of Education on Public Trust and Consent Preferences With Residual Newborn Screening Dried Blood spots.
Rothwell E; Wong B; Anderson RA; Botkin JR
J Empir Res Hum Res Ethics; 2016 Jul; 11(3):231-6. PubMed ID: 27387457
[TBL] [Abstract][Full Text] [Related]
5. The use of newborn screening dried blood spots for research: the parental perspective.
Gong LM; Tu WJ; He J; Shi XD; Wang XY; Li Y
J Bioeth Inq; 2012 Jun; 9(2):189-93. PubMed ID: 23180262
[TBL] [Abstract][Full Text] [Related]
6. IRB review and public health biobanking: a case study of the Michigan BioTrust for Health.
Mongoven A; McGee H
IRB; 2012; 34(3):11-6. PubMed ID: 22830178
[No Abstract] [Full Text] [Related]
7. Community perspectives on public health biobanking: an analysis of community meetings on the Michigan BioTrust for Health.
Thiel DB; Platt T; Platt J; King SB; Kardia SL
J Community Genet; 2014 Apr; 5(2):125-38. PubMed ID: 23893769
[TBL] [Abstract][Full Text] [Related]
8. Public attitudes regarding the use of residual newborn screening specimens for research.
Botkin JR; Rothwell E; Anderson R; Stark L; Goldenberg A; Lewis M; Burbank M; Wong B
Pediatrics; 2012 Feb; 129(2):231-8. PubMed ID: 22250018
[TBL] [Abstract][Full Text] [Related]
9. The view of Hong Kong parents on secondary use of dried blood spots in newborn screening program.
Hui LL; Nelson EAS; Deng HB; Leung TY; Ho CH; Chong JSC; Fung GPG; Hui J; Lam HS
BMC Med Ethics; 2022 Nov; 23(1):105. PubMed ID: 36319979
[TBL] [Abstract][Full Text] [Related]
10. An Assessment of a Shortened Consent Form for the Storage and Research Use of Residual Newborn Screening Blood Spots.
Rothwell E; Goldenberg A; Johnson E; Riches N; Tarini B; Botkin JR
J Empir Res Hum Res Ethics; 2017 Dec; 12(5):335-342. PubMed ID: 29073807
[TBL] [Abstract][Full Text] [Related]
11. Attitude to extended use and long-term storage of newborn screening blood spots in Japan.
Fujii C; Sato Y; Harada S; Kakee N; Gu YH; Kato T; Shintaku H; Owada M; Hirahara F; Umehashi H; Yoshino M
Pediatr Int; 2010 Jun; 52(3):393-7. PubMed ID: 20003144
[TBL] [Abstract][Full Text] [Related]
12. Prenatal Education of Parents About Newborn Screening and Residual Dried Blood Spots: A Randomized Clinical Trial.
Botkin JR; Rothwell E; Anderson RA; Rose NC; Dolan SM; Kuppermann M; Stark LA; Goldenberg A; Wong B
JAMA Pediatr; 2016 Jun; 170(6):543-9. PubMed ID: 27043416
[TBL] [Abstract][Full Text] [Related]
13. Information and consent for newborn screening: practices and attitudes of service providers.
Kerruish NJ; Webster D; Dickson N
J Med Ethics; 2008 Sep; 34(9):648-52. PubMed ID: 18757632
[TBL] [Abstract][Full Text] [Related]
14. Not without my permission: parents' willingness to permit use of newborn screening samples for research.
Tarini BA; Goldenberg A; Singer D; Clark SJ; Butchart A; Davis MM
Public Health Genomics; 2010; 13(3):125-30. PubMed ID: 19602864
[TBL] [Abstract][Full Text] [Related]
15. Consent for newborn screening: the attitudes of health care providers.
Miller FA; Hayeems RZ; Carroll JC; Wilson B; Little J; Allanson J; Bytautas JP; Paynter M; Christensen R; Chaktraborty P
Public Health Genomics; 2010; 13(3):181-90. PubMed ID: 19776551
[TBL] [Abstract][Full Text] [Related]
16. Testing an online, dynamic consent portal for large population biobank research.
Thiel DB; Platt J; Platt T; King SB; Fisher N; Shelton R; Kardia SL
Public Health Genomics; 2015; 18(1):26-39. PubMed ID: 25359560
[TBL] [Abstract][Full Text] [Related]
17. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing.
Dhondt JL
J Pediatr; 2005 Sep; 147(3 Suppl):S106-8. PubMed ID: 16202772
[TBL] [Abstract][Full Text] [Related]
18. Public support for the use of newborn screening dried blood spots in health research.
Duquette D; Rafferty AP; Fussman C; Gehring J; Meyer S; Bach J
Public Health Genomics; 2011; 14(3):143-52. PubMed ID: 21178324
[TBL] [Abstract][Full Text] [Related]
19. Waiving informed consent in newborn screening research: balancing social value and respect.
Tarini BA; Burke W; Scott CR; Wilfond BS
Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):23-30. PubMed ID: 18200521
[TBL] [Abstract][Full Text] [Related]
20. Expanding the Australian Newborn Blood Spot Screening Program using genomic sequencing: do we want it and are we ready?
White S; Mossfield T; Fleming J; Barlow-Stewart K; Ghedia S; Dickson R; Richards F; Bombard Y; Wiley V
Eur J Hum Genet; 2023 Jun; 31(6):703-711. PubMed ID: 36935418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
